In a landmark update that has eased the anxieties of thousands of hopeful parents, leading fertility specialists have confirmed that babies born through in vitro fertilisation (IVF) are as safe as those conceived naturally. The reassurance comes after a comprehensive review of recent data showing that advances in embryo selection, genetic screening and personalised ovarian stimulation have dramatically lowered the risks traditionally associated with assisted reproduction.
Background
Since the birth of Louise Brown in 1978, the first IVF baby, the technology has evolved from a fragile experimental procedure to a routine, highly regulated medical intervention. Today, more than 8 million children worldwide are born each year via IVF, a figure that has grown steadily as clinics adopt newer protocols and as societal acceptance of assisted reproduction increases.
Despite the success, many couples still harbour doubts about the long‑term health of IVF babies. Common concerns include the possibility of genetic abnormalities, low birth weight, preterm delivery and the risk of multiple pregnancies. These worries are often amplified by media reports and anecdotal stories, leading to a perception that IVF babies may face unique challenges.
“The first baby born through IVF was in 1978, and since then, millions of children worldwide have been born using this technology,” says Dr Sreevani Kotha, Director and Head of 9M Fertility at Ankura Hospital. “The key point is that once the embryo is transferred to the uterus, it develops just like any other pregnancy.”
Key Developments
Experts point to several technological and procedural breakthroughs that have made IVF baby safety a reality:
- Single Embryo Transfer (SET) – By implanting only one high‑quality embryo, clinics have reduced the incidence of twins and triplets from 30% to under 5% in many centres.
- Preimplantation Genetic Testing (PGT) – Screening embryos for chromosomal abnormalities before transfer cuts the risk of Down syndrome, Turner’s syndrome and other genetic disorders by up to 90%.
- Endometrial Receptivity Analysis (ERA) – This test identifies the optimal window for embryo transfer, improving implantation rates and reducing miscarriage risk.
- Personalised Ovarian Stimulation – Tailoring medication doses to a woman’s hormonal profile minimizes ovarian hyperstimulation syndrome (OHSS) and improves egg quality.
- Advanced Embryo Culture Media – New media formulations support embryo development in conditions that mimic the natural uterine environment, enhancing viability.
Statistically, the latest cohort studies show that the rate of preterm birth (<37 weeks) in IVF pregnancies has fallen from 12% in the early 2000s to 6% in 2025, while low birth weight (<2500 g) rates have dropped from 9% to 4%. These figures are comparable to the national averages for naturally conceived babies.
Impact Analysis
For couples navigating infertility, the improved safety profile translates into clearer decision‑making and reduced emotional burden. Students and young professionals, in particular, can now consider IVF without the fear that their future children will inherit health complications directly linked to the procedure.
Key takeaways for prospective parents:
- Choose a certified clinic – Look for accreditation from national bodies such as the Indian Society for Assisted Reproduction (ISAR) or the American Society for Reproductive Medicine (ASRM).
- Undergo preconception counselling – Comprehensive health screening can identify modifiable risk factors such as hypertension or thyroid disorders.
- Opt for SET whenever possible – Even if you have multiple good embryos, a single transfer reduces the chance of multiples and associated complications.
- Ask about PGT and ERA – These tests are increasingly offered as standard care and can significantly improve outcomes.
Financially, the cost of IVF has also become more predictable. In India, the average cost per cycle has decreased by 15% over the past three years, largely due to economies of scale and the adoption of automated lab equipment.
Expert Insights
Dr Kotha elaborates on the practical aspects of ensuring IVF baby safety: “We now have the tools to select the healthiest embryo and to screen for genetic issues before implantation. This proactive approach means that the baby’s health is safeguarded from the very beginning.”
Dr Anil Sharma, a reproductive endocrinologist at Apollo Fertility, adds, “The data show that the risk of congenital anomalies in IVF babies is no higher than in naturally conceived ones. The real differentiator is the quality of care during the entire treatment journey.”
For patients, the experts recommend a structured care pathway:
- Pre‑treatment assessment – Baseline hormone levels, ultrasound, and a detailed medical history.
- Customized stimulation protocol – Adjusted to the patient’s ovarian reserve and response.
- Embryo grading and selection – Using time‑lapse imaging to assess developmental milestones.
- Post‑transfer monitoring – Early ultrasounds at 6–8 weeks to confirm viability and detect any complications.
- Long‑term follow‑up – Routine pediatric check‑ups to monitor growth and development.
“We see a significant drop in complications when patients adhere to the full treatment protocol,” notes Dr Sharma. “Skipping steps or choosing a sub‑standard clinic can negate the safety benefits.”
Looking Ahead
While current practices have already made IVF baby safety a reality, research continues to push the envelope. Emerging technologies such as artificial intelligence‑driven embryo selection algorithms, non‑invasive prenatal testing (NIPT) for early detection of chromosomal abnormalities, and CRISPR‑based gene editing hold promise for further reducing risks.
Regulatory bodies are also tightening standards. In 2026, the Indian Ministry of Health announced a new certification framework that will require clinics to maintain a 95% live birth rate and a <5% multiple pregnancy rate to remain accredited.
For patients, staying informed about these developments is crucial. Regular consultations with a fertility specialist, participation in patient support groups, and reviewing clinic performance metrics can help ensure that the chosen treatment aligns with the latest safety standards.
In summary, the convergence of advanced laboratory techniques, personalised medicine, and stringent regulatory oversight has transformed IVF from a high‑risk procedure into a safe, reliable pathway to parenthood. Couples can now approach treatment with confidence, knowing that the likelihood of a healthy, naturally developing baby is higher than ever.
Reach out to us for personalized consultation based on your specific requirements.